Saamya Biotech (India) Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 29-12-2024
- Paid Up Capital ₹ 24.88 Cr
as on 29-12-2024
- Company Age 22 Year, 5 Months
- Last Filing with ROC 31 Mar 2016
- Satisfied Charges ₹ 5.00 Cr
as on 29-12-2024
- Revenue -49.60%
(FY 2016)
- Profit 35.01%
(FY 2016)
- Ebitda -154.58%
(FY 2016)
- Net Worth -1.54%
(FY 2016)
- Total Assets 8.77%
(FY 2016)
About Saamya Biotech (India)
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 24.88 Cr.
The company has closed loans amounting to ₹5.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Saamya Biotech (India) Limited India are Manivardhan Yala as CEO and Yala Reddy as Cfo. Yala Reddy, Manivardhan Yala, Podduturi Reddy, and Two other members serve as directors at the Company.
- CIN/LLPIN
L24239AP2002PLC039449
- Company No.
039449
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2002
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Listed
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Saamya Biotech (India) Limited offer?
Saamya Biotech (India) Limited offers a wide range of products and services, including Pharmaceutical Services, Biotech Consultancy Services.
Who are the key members and board of directors at Saamya Biotech (India)?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Manivardhan Yala | Managing Director | 05-Sep-2015 | Current |
Yala Reddy | CFO | 30-Sep-2008 | Current |
Board Members(4)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Yala Reddy | Whole-Time Director and Cfo | 13-Aug-2002 | Current |
Podduturi Reddy | Director | 27-Dec-2007 | Current |
Santosh Sawant | Director | 13-Nov-2015 | Current |
Reddy Pannala | Director | 18-Jul-2008 | Current |
Financial Performance of Saamya Biotech (India).
Saamya Biotech (India) Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 49.6% decrease. The company also saw a substantial improvement in profitability, with a 35.01% increase in profit. The company's net worth dipped by a decrease of 1.54%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Saamya Biotech (India)?
In 2016, Saamya Biotech (India) had a promoter holding of 35.67% and a public holding of 64.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Sree Ekadanta Engineering Consultants Private LimitedActive 22 years 1 month
Manivardhan Yala is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
State Bank Of India Creation Date: 09 Mar 2007 | ₹5.00 Cr | Satisfied |
How Many Employees Work at Saamya Biotech (India)?
Unlock and access historical data on people associated with Saamya Biotech (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Saamya Biotech (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saamya Biotech (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.